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A P P L I E D  S C I E N C E S  A N D  E N G I N E E R I N G
Trabecular bone organoid model for studying 
the regulation of localized bone remodeling
Yongkuk Park1, Eugene Cheong2, Jun-Goo Kwak3, Ryan Carpenter1,  
Jae-Hyuck Shim4, Jungwoo Lee1,3*
Trabecular bone maintains physiological homeostasis and consistent structure and mass through repeated cycles 
of bone remodeling by means of tightly localized regulation. The molecular and cellular processes that regulate 
localized bone remodeling are poorly understood because of a lack of relevant experimental models. A tissue- 
engineered model is described here that reproduces bone tissue complexity and bone remodeling processes with 
high fidelity and control. An osteoid-inspired biomaterial—demineralized bone paper—directs osteoblasts to de-
posit structural mineralized bone tissue and subsequently acquire the resting-state bone lining cell phenotype. 
These cells activate and shift their secretory profile to induce osteoclastogenesis in response to chemical stimu-
lation. Quantitative spatial mapping of cellular activities in resting and activated bone surface coculture showed 
that the resting-state bone lining cell network actively directs localized bone remodeling by means of paracrine 
signaling and cell-to-cell contact. This model may facilitate further investigation of trabecular bone niche biology.
INTRODUCTION
Trabecular bone is a dynamic, multifunctional tissue that regulates 
mineral homeostasis, blood-forming, and mechanical structure in 
response to changing physical stresses and physiological needs (1, 2). 
Trabecular bone undergoes repeated remodeling by the paired ac-
tion of osteoclasts, which break down bone, and osteoblasts, which 
form new bone (3). During active bone remodeling, osteoblasts build 
osteoids, collagen-based structures of extracellular matrix (ECM) 
that they then mineralize to form new lamellar bone (3). After an 
osteoid has been mineralized, osteoblasts on the bone surface differ-
entiate into their resting state: bone lining cells (3). The cellular pro-
cesses of the bone remodeling cycle occur at localized spots under 
tight regulation by stimulatory and suppressive molecules such as 
receptor activator of nuclear factor B ligand (RANKL) and its sol-
uble decoy receptor, osteoprotegerin (OPG) (4). RANKL stimulates 
bone marrow mononuclear cells (BMMs) to differentiate into 
osteoclasts by binding to its receptor, RANK, whereas OPG blocks 
RANK-RANKL signaling by competitively binding to RANKL and 
thus suppressing osteoclast differentiation (4).
Active- and resting-state bone tissue surfaces coexist within 
every bone. There are 1 million active remodeling sites in a normal 
adult skeleton at any one time, which account for 5 to 20% of the 
total bone surface (5, 6). Molecular regulation is essential to localize 
bone remodeling activity and prevent unnecessary remodeling and 
overresorption. Imbalanced bone remodeling can lead to osteo-
porosis (7), decreased bone marrow hematopoietic activity (8), or in-
creased risk of bone metastasis (9). To develop effective treatments 
for these conditions, it is imperative that we understand how local-
ized bone remodeling is regulated in the trabecular bone cavities.
Spatiotemporal profiles of regulatory molecules may play a crit-
ical role in directing localized bone remodeling activity. In normal 
bone remodeling, trabecular bone undergoes continuous structural 
change but maintains consistent morphology and mass (10). This 
implies that localized bone remodeling is in part regulated by bone 
turnover rate and morphology. Countergradients of stimulative and 
inhibitory molecules are key regulatory mechanisms in localized 
morphogenic activity that direct the size and shape of tissue develop-
ment and regeneration (11, 12). We postulate that the same principle 
applies to the regulation of trabecular bone remodeling. Osteoblasts 
secrete both stimulative and suppressive molecules, and their secre-
tory profiles change depending on whether they are in an active or 
a resting state (13). Secreted regulatory molecules form diffusion 
gradients as a function of the diameters of the trabecular bone cav-
ities (14). Therefore, key determinants of the spatiotemporal profile 
of regulatory molecules in trabecular bone cavities are the extent of 
remodeling activity and the cavity diameter. To investigate this con-
cept in more detail, a new experimental model is needed.
Available experimental models have limited ability to reproduce 
the spatiotemporal complexity of trabecular bone. Mouse models 
have limited utility to investigate cellular and molecular processes 
of trabecular bone remodeling because the inner bone surface is 
anatomically inaccessible and researchers have limited ability to 
manipulate the structure and dimensions of the trabecular bone. 
Explanted bone chips are more accessible, but local manipulation of 
cellular metabolic activity and dimensional control of bone are limited, 
and reproducibility is low because tissue dimensions are variable and 
vascular occlusion decreases cell viability over time (15).
In vitro bone tissue models allow greater experimental control 
and access, and many biomaterials and material-processing techniques 
have been introduced to reproduce the material and structural prop-
erties of bone ECM in in vitro bone tissue models (16). However, 
existing in vitro models do not reproduce the bone tissue complexity 
and molecular and cellular processes of bone remodeling (17). For 
example, compact bone disks have been used to assess osteoclasts 
function (18) and demineralized trabecular bones have been used to 
culture osteoblasts (19). However, grinding compact bone is burden-
some and low throughput, and the opacity of bone restricts in situ 
optical microscopy. Demineralized trabecular bone supports high 
osteogenic activity (19), but its three-dimensional (3D) architecture 
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is determined by the individual bone matrix and is difficult to stan-
dardize or manipulate for mechanistic investigation. Collagen gels 
provide a biochemical milieu comparable to that of bone ECM but 
fail to reproduce the density and structural organization of collagen 
fibers (20). Hydroxyapatites mimic inorganic aspects of bone ECM 
but lack the organic materials that are known to provide biochemical 
signals (16). Blends of organic and inorganic materials better repre-
sent bone ECM but do not provide multiscale structural complexity 
(16). Techniques have been developed to produce nanoscale surface 
roughness, microscale pore geometry, and macroscale trabecular 
architecture in biomaterials—including porogen-based porous archi-
tecture, electrospun fibrous meshwork, and 3D-printed trabecular 
bone structure (21)—but these processes do not recapitulate the 
hierarchical composite structures of trabecular bone in the critical 
dimensions of lamellae (5 to 25 m), collagen fibers (1 to 2 m), and 
collagen fibrils (10 to 300 nm) (20). In addition, most in vitro bio-
material studies have focused on either osteoblasts or osteoclasts, 
but few studies have involved osteoblasts and osteoclasts in cocul-
ture (22, 23). In the body, active osteoblasts and osteoclasts are only 
present transiently at local spots, while most of the bone surface is 
in a quiescent state characterized by bone lining cells (6). The role of 
bone lining cells in the initiation and termination of the bone re-
modeling cycle has not been investigated, and failures in initiation 
or termination of the bone remodeling cycle could be a critical factor 
in bone remodeling imbalance.
Here, we report the development of a trabecular bone organoid 
model that reproduces essential extracellular complexity and cellular 
processes of trabecular bone cavities. We reproduced unmineralized 
bone ECM—the osteoid—with thin slices of demineralized cortical 
bone. This material is mechanically durable, semitransparent, and 
has controlled thickness and surface area. We named this biomaterial 
demineralized bone paper (DBP). We explored whether DBP di-
rects osteoblasts to form mineralized bone tissue and acquire the 
bone lining cell phenotype. We then cocultured primary murine 
osteoblasts and BMMs and applied chemical stimulants to reproduce 
the bone remodeling cycle. We created defined spatiotemporal pro-
files of regulatory molecules by combining DBP surfaces containing 
active- and resting-state osteoblasts. Last, we conducted quantitative 
spatial mapping of cellular activities to investigate how localized 
bone remodeling activity is regulated. We expect that the trabecular 
bone organoid model will facilitate further study of the complex and 
dynamic regulation of bone remodeling processes with high fidelity 
and an unprecedented level of analytical power.
RESULTS
DBP effectively simulates the trabecular osteoid
To reproduce the bone remodeling process in a controlled and ana-
lytical manner, we developed a biomaterial that mimics the dense 
structural collagen matrix of the unmineralized osteoid with thin 
sections of demineralized bovine compact bone. First, we established 
a method to rapidly demineralize bone matrix. We cut bovine fe-
murs into 4- to 5-cm blocks, removed marrow and connective 
tissue, and dissolved the fat in methanol and chloroform. Then, we 
submerged the blocks in 1.2 N hydrochloric acid to dissolve bone 
mineral. The outer layer of bone turned semitransparent after 5 days, 
but demineralization progressed little over the next 4 weeks because 
diffusion through the dense collagen matrix was limited (Fig. 1A). 
Under the hypothesis that cyclic hydrostatic pressure can promote 
the demineralization process, we devised a programmable pressure 
chamber operated with compressed air (Fig. 1B and fig. S1). We found 
that demineralization depth increased when hydrostatic pressure was 
applied and increased further when hydrostatic pressure was applied 
in a cyclic pattern. The most effective operating condition was 4 bar 
pressure with a 10-s on/off interval. This process demineralized 
5.1 ± 0.3 mm compact bone matrix in 5 days (Fig. 1C and fig. S2). 
Radiographic images confirmed that the processed bone tissue was 
fully demineralized (Fig. 1D).
We then cryosectioned a demineralized compact bone block to 
generate 3 × 4–cm slices and biopsy-punched the slices to obtain 
disks that will fit in multiwell plates (Fig. 1E). We found that 20 m 
is a practical thickness that provides 80% of the light transmittance 
of tissue culture plate (TCP) yet retains sufficient mechanical dura-
bility for handling (stiffness: 6.5 ± 0.4 kPa) (Fig. 1F). Transmission 
micrographs confirmed a well-preserved bony ECM structure that 
exhibited distinct morphology depending on sectioning direction: 
Vertical sections had parallel lamellar structure, and transverse sec-
tions had concentric lamellar layers. Scanning electron microscopy 
(SEM) showed densely aligned collagen fiber bundles (Fig. 1G). 
Collagen-hybridizing peptides (CHPs) that specifically bind to dam-
aged collagen fibrils (24) did not bind to demineralized bone slices. 
In addition, multiphoton second harmonic imaging that visualizes 
intact fibrillar collagen structure (25) revealed aligned collagen fibers 
(Fig. 1H). These results indicate the preserved biochemical integrity 
of the collagen. Last, we removed residual cellular materials from 
demineralized bone sections by treating with sodium dodecyl sul-
fate (Fig. 1I). We named these sheets of demineralized bone ma-
trix DBP.
DBP directs rapid and structural mineralization  
by osteoblasts
To monitor long-term cellular processes on DBP, we collected osteo-
blasts from DsRed reporter mice by gently crushing femoral and tibial 
bones and treating the bone chips with collagenase (Fig. 2A and 
movie S1). We used TCP as a control substrate for DBP. Although 
TCP lacks bone-relevant ECM, it is similar to DBP in that it supports 
reproducible and analytical osteogenic cell culture experiments be-
cause it is standardized, bioactive, and has optical transparency. Osteo-
blasts cultured on vertically sectioned DBP for 3 days developed 
elongated morphology aligned with the underlying lamellar structure 
of the demineralized bone (±4.9°), whereas osteoblasts cultured on 
TCP had irregular shape and inconsistent alignment (±25.6°) (Fig. 2B 
and movie S2). Multiphoton second harmonic imaging microscopy 
showed that osteoblasts on DBP deposited collagen fibers that were 
directionally aligned with the lamellar structure of the bone (±7.3°), 
whereas those cultured on TCP had irregular collagen fiber alignment 
(±26.2°) (Fig. 2C and movie S3). SEM imaging further confirmed 
that osteoblasts on DBP deposit collagen fibers directionally (fig. S3).
Next, we characterized mineralization by osteoblasts in osteogenic 
differentiation medium. Time-course images with alizarin red min-
eral stain showed that osteoblasts on DBP completely covered the 
surface after 4 days and continued to deposit minerals for more 
than 2 weeks. In the same time period, osteoblasts on TCP deposited 
collagen but deposited minerals in only a few localized regions (Fig. 2D). 
We then conducted fluorochrome calcein staining to characterize 
mineral deposition patterns. On DBP, mineral deposition began with 
small granules embedded in the preexisting collagen matrix that 
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contrast, on TCP, mineral deposition occurred at local spots where 
clusters of osteoblasts formed mineralized nodules. Cross-sectional 
confocal imaging revealed that, on DBP, most mineral deposition 
occurred beneath osteoblasts (Fig. 2E). After 3 weeks of culture on 
100-m-thick DBP, osteoblasts typically mineralized to a depth of 
18.6 ± 3.8 m (Fig. 2F). Last, we characterized the deposited mineral 
structure without organic components via thermal decomposition. 
Cell-derived mineral layers exhibited long-range crystalline-like 
morphology. By contrast, mineral layers that were only formed 
chemically with simulated body fluid (SBF) had a disorganized struc-
ture (Fig. 2G). SEM showed that cell-derived mineral had densely 
fused, smooth mineral layers, whereas chemically formed mineral 
layers exhibited coarse aggregation of mineral granules (Fig. 2H). 
The characteristic surface roughness of chemically formed mineral 
layers was 2.3-fold higher than that of mineral layers formed by osteo-
blasts (fig. S5). These results indicate that DBP directs osteoblasts to 
proceed with rapid and structural mineralization similar to that seen 
in in vivo osteoid bone (20, 26).
Osteoblasts on DBP acquire the bone lining cell phenotype
We investigated whether DBP can direct osteoblasts to acquire the 
bone lining cell phenotype and associated cellular organization and 
communication (27). Osteoblasts seeded on DBP decreased migration 
and proliferation over time. After they were cultured for 2 weeks, 
osteoblasts on DBP showed twofold decreased motility (157 ± 15 m/
day), whereas those on TCP maintained high motility (309 ± 29 m/
day) (Fig. 3A). Immunofluorescent staining of 1-week cultures with 
mitogenic marker Ki67+ showed four times down-regulated prolif-
eration on DBP but three times up-regulated mitogenic activity on 
TCP (Fig. 3B). We then examined whether osteoblasts cultured on 
DBP develop functional gap junctions. Immunofluorescent staining 
confirmed that osteoblasts express connexin 43, a key molecule in 
gap junction (28). Gap junction–mediated cellular communication 
was further confirmed by time-lapse fluorescent imaging of Ca2+, 
which showed sequential Ca2+ influx to adjacent bone lining cells 
under potassium stimulation (Fig. 3C and movie S4). These data 
confirm that osteoblasts cultured on DBP for 1 week take on the 
Fig. 1. Development and characterization of DBP. (A) A bovine femur was cut into blocks, (i) cleaned, and (ii) demineralized in HCl solution. (iii) Demineralization was 
limited by the diffusion limit. (B) We accelerated demineralization with a programmable cyclic pressure chamber. (C) Cross-sectional images of the bones processed in 
three different conditions and soaked in rhodamine dye show demineralization depth (n = 5). (D) Radiographs of processed and unprocessed bone blocks confirmed full 
demineralization (n = 3). (E) (i) Demineralized bone was sectioned into 20- to 100-m slices to form DBP and (ii) cut into disks that fit multiwell plates. (F) (i) Cross sections 
of DBP with three thicknesses and corresponding (ii) optical transparency [percentage that of tissue culture plate (TCP)] and (iii) stiffness (n = 6). (G) DBP preserves the 
micro/nano collagen structure of bone. (i) Transverse-sectioned DBP has concentric lamellae and (ii) vertically sectioned DBP has parallel lamellae and (iii) densely aligned 
collagen fibril bundles [scanning electron micrographs (SEM)]. (H) Biochemical integrity of collagen is preserved versus heat-denatured control. (i) Fluorescent collagen 
hybridizing peptide stained images; (ii) multiphoton second harmonic generation images. (I) Removal of cellular materials by SDS was confirmed by nuclear 4′,6-diamidino- 
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bone lining cell phenotype. Hereafter, we will refer to osteoblasts that 
have been cultured on DBP for more than 1 week as bone lining cells.
We developed two functional assays to determine whether cells 
that have taken on the bone lining cell state can regain osteogenic 
activity. First, we developed a bone surface healing assay. We scratched 
the surface of DBP containing bone lining cells and monitored the 
subsequent activation of lining cells and increase in surface cover-
age. Time-lapse imaging over 5 days showed that migratory activity 
of bone lining cells increased transiently and then gradually returned 
to a resting state as the damaged area became completely confluent 
(Fig. 3D and movie S5). Second, we developed an osteoblast pheno-
typic switching assay. We released established bone lining cells from 
DBP by degrading the DBP with collagenase. We then cultured the 
released cells on TCP and found that they resumed their migratory 
and proliferative activity (movie S6). Quantitative analysis of Ki67+ 
cells confirmed that bone lining cells released from DBP and cultured 
on TCP for 1 week recovered mitogenic activity comparable to that 
of osteoblasts that were continuously cultured on TCP (Fig. 3E). 
When the TCP-expanded osteoblasts were detached and reintroduced 
onto DBP, they regained the bone lining cell phenotype. This cycle 
of phenotypic switching from resting to active states by alternating 
DBP and TCP substrates was repeated at least three times. With each 
cycle, the time required to reach 80% confluency on TCP increased: 
8 days in the first cycle, 15 days in the second cycle, and 30 days in 
the third cycle. Alizarin red staining showed that mineral deposition 
activity was similar in each of the three cycles (Fig. 3F). These data 
indicate that cells that take on the bone lining cell phenotype on 
DBP retain the ability to revert to active state osteoblasts, as they 
would in the bone remodeling cycle in vivo (3, 29).
The microenvironment of DBP supports the bone 
remodeling cycle
Bone remodeling begins when chemical or mechanical stimulation 
triggers a shift in the local profile of osteogenic regulatory molecules 
that induces BMMs to differentiate into osteoclasts. When stimulation 
ceases, up-regulated stimulatory molecules return to resting levels 
Fig. 2. Osteoblasts rapidly mineralize DBP in a way that preserves the underlying lamellar structure. (A) (i) Osteoblasts (OBs) harvested from DsRed mice. (ii) Fluores-
cent micrograph of OBs migrating out from mouse bone chips. (B) Morphology of OBs grown on vertically sectioned DBP and TCP for 1 week: (i) immunofluorescent 
staining of actin filaments; (ii) circular histogram of cell alignment angles (n = 100). (C) Collagen deposition by OBs on DBP and TCP for 1 week: (i) multiphoton second 
harmonic generation (SHG) images; (ii) circular histogram of collagen fiber alignment angles (n = 100). (D) Mineral deposition by OBs on DBP and TCP: (i) alizarin red mineral 
stain on days 0 and 4; (ii) time-course measurement of mineral deposition for 16 days (n = 3). (E) (i) Confocal images of fluorescent calcein staining show mineral deposition 
pattern on DBP and TCP after 1-week culture. (ii) z-staked cross-sectional image. (F) Cross section of 100-m-thick DBP stained with alizarin red after 3-week culture of 
OBs (n = 3). (G and H) Comparison of the mineral layer deposited by 3-week culture of OBs and chemical reaction in simulated body fluid without OBs (both subjected to 
thermal decomposition): (G) bright-field micrographs. (H) SEM and surface roughness quantified by optical profiler (n = 6) (*P < 0.05, **P < 0.01). Photo credit: Yongkuk Park, 
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and bone remodeling terminates (3). To reproduce the activation of 
a bone remodeling cycle, we stimulated bone lining cells on DBP to 
become active and then added BMMs to see whether the BMMs dif-
ferentiated into osteoclasts and initiated bone remodeling (Fig. 4A). 
First, we used enzyme-linked immunosorbent assays to measure the 
profiles of representative stimulative and suppressive molecules—
RANKL and OPG—secreted by bone lining cells on DBP. The bone 
lining cells secreted high OPG (12.7 ± 0.5 ng/ml) and low RANKL 
(0.09 ± 0.001 ng/ml). The ratio of OPG to RANKL was 0.007, which 
indicates a highly suppressive molecular milieu for the initiation of 
bone remodeling cycle. We then examined whether bone lining cells 
on DBP change their secretory profile when exposed to chemical 
instigators of bone remodeling, vitamin D3 (VD3) and prostaglandin 
E2 (PGE2) (22). When exposed to a physiological range of VD3 (10 nM) 
and PGE2 (1 M), the secretion profile of the bone lining cells 
markedly shifted: OPG decreased sixfold and RANKL increased 
30-fold. The shifted RANKL/OPG ratio was 1.47, which indicates a 
permissive molecular niche for bone resorption. Without additional 
stimulation, the secretion profile gradually returned to the initial 
resting state in 1 week (Fig. 4B). In contrast, osteoblasts on TCP 
secreted moderate levels of OPG (1.6 ± 0.02 ng/ml) and RANKL 
(1.1 ± 0.04 ng/ml) at a ratio of 0.65, nearly 100 times higher than the 
ratio secreted by bone lining cells on DBP. VD3 and PGE2 stimula-
tion also shifted the secretory profile of osteoblasts on TCP to a 
RANKL/OPG ratio to 34.2. After stimulation, the cells on TCP re-
turned to the initial state of molecular secretion more slowly than 
did those on DBP (fig. S6).
Next, we examined whether the up-regulated secretion of stimu-
latory molecules by activated bone lining cells on DBP can induce 
BMMs to differentiate into osteoclasts. We used green fluorescent 
protein (GFP)–expressing osteoblasts and DsRed-expressing BMMs 
to facilitate long-term, time-lapse fluorescent monitoring of multi-
cellular processes in the DBP. We stimulated established bone lining 
cells with VD3 and PGE2 and cocultured them with 1 × 106 BMMs. 
After 1 week, multinucleated osteoclasts began to appear (Fig. 4C 
and movie S7). SEM showed localized removal of the mineral layer 
and exposure of the collagen fibers underlying osteoclasts, confirm-
ing functional osteoclasts (Fig. 4D). These results indicate that shifted 
secretion of regulatory molecules was sufficient to induce BMMs to 
differentiate into osteoclasts that resorbed mineral. We repeated the 
process on TCP for comparison and found that osteoclasts began to 
emerge on TCP after 3 days (movie S8).
Fig. 3. OBs on DBP acquire the bone lining cell phenotype. (A) OBs on DBP migrated more slowly than those on TCP (n = 25). (B) OB on DBP proliferated less than those 
on TCP (n = 3). (C) OBs on DBP developed gap junction–mediated intercellular communication. (i) Immunofluorescent staining of connexin 43. (ii) Time-lapse monitoring 
of fluorescent Ca2+ flux in adjacent cells. (D) Bone surface healing assay: (i) Repair of mineral surface was monitored after scratch in 1-week culture of OBs on DBP; (ii) 
quantitative measurement of transiently increased OB migration during healing process (n = 3 to 5). (E) OBs cultured on DBP for 1-week regained proliferative activity 
when cultured on TCP. (i) Fluorescent images of mature OBs migrating out of DBP treated with collagenase and proliferating on TCP. (ii) Within 1 week, mature OBs 
released from DBP and grown on TCP regained mitogenic activity similar to that of OBs grown continuously on TCP (n = 10). (F) OB phenotypic switching assay: (i) exper-
imental procedure and metabolic state changes in OBs. (ii) The cycle of switching from resting state on DBP to proliferative state on TCP was successfully repeated 
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Detailed time-lapse imaging captured cellular migration activity 
on both materials. Stimulated osteoblasts migrated two times faster 
than their unstimulated counterparts on both DBP and TCP (Fig. 4E). 
On DBP, osteoclasts cocultured with stimulated osteoblasts migrated 
twice as fast as osteoclasts stimulated in the absence of osteoblasts. 
On TCP, osteoclasts cocultured with stimulated osteoblasts migrated 
at the same rate as osteoclasts stimulated in the absence of osteo-
blasts (Fig. 4F). On DBP, osteoclasts underwent cell fusion and cell 
fission, in which individual cells separated from the multicellular 
body (Fig. 4G and movie S9) (30). By contrast, osteoclasts on TCP 
underwent cell fusion repeatedly until the cells became giant and 
multinucleated and cell death occurred by apoptosis. As a result of 
the repeated cell fusion, the osteoclasts on TCP exhibited a broad 
range of cell sizes (720 ± 400 m2). Osteoclasts on DBP were signifi-
cantly smaller and had narrower cell size distribution (140 ± 43 m2), 
similar to that seen in trabecular bone (31). Osteoclasts cultured on 
DBP and TCP had a similar ratio of number of nuclei to cell area 
(fig. S7). Active osteoblasts on DBP held their position in the pres-
ence of osteoclasts, whereas osteoblasts on TCP were pushed aside 
by migrating osteoclasts (Fig. 4H). When osteoclasts on TCP under-
went apoptosis, they left behind large actin-ring structures that pre-
vented migration of neighboring osteoblasts. Instead, BMMs were 
the first to migrate to the region that had been occupied by the dead 
cell body, because they are floating cells, and osteoblasts entered 
Fig. 4. The bone remodeling cycle is recapitulated by coculture of bone lining cells and BMMs on DBP under chemical stimulation. (A) Experimental procedure to 
simulate a bone remodeling cycle. (B) Stimulation of bone lining cells on DBP with VD3 and PGE2 caused a temporary increase in RANKL/OPG secretion ratio (n = 3 to 5). 
(C) Representative fluorescent images show that activated OBs (green) induce BMMs (red) to differentiate into osteoclasts (OCs). (D) SEM confirmed functional mineral 
resorption by OCs. (E) Stimulated OBs migrated two times faster than their unstimulated counterparts on both DBP and TCP (n = 4). (F) OC migration in single culture and 
coculture on DBP and TCP (n = 10). (G) On DBP, OCs underwent both cell fission and cell fusion. (H) On TCP, OBs were readily pushed by large multinucleated OCs, whereas 
on DBP, the OBs stayed in place. (I) On TCP, OCs underwent cell fusion repeatedly until cells became giant and underwent apoptosis. After apoptosis, the large actin-ring 
structure of the OC remained and prevented immediate migration of neighboring OBs. (J) (i) Alkaline phosphatase (ALP) staining of OBs and (ii) quantitative comparison 
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10 hours later. A similar process occurred on DBP but was less pro-
nounced because the osteoclasts were smaller and apoptosis was 
infrequent (Fig. 4I and movie S10).
Recent data suggest that osteoblasts promote osteoclast differen-
tiation and osteoclasts enhance osteoblast activity (32). We examined 
the coupling of osteoblast and osteoclast activities by measuring 
changes in osteoblast- and osteoclast-specific functional enzyme 
activities under VD3 and PGE2 stimulation. We focused on alkaline 
phosphatase (ALP), which is expressed by osteoblasts during mineral 
deposition, and tartrate-resistant acid phosphatase (TRAP), which 
is expressed by osteoclasts during mineral resorption. Before stim-
ulation, osteoblasts expressing ALP covered 50% of the surface of 
DBP and 67% of the surface of TCP; after stimulation, this was re-
duced by half on both substrates (Fig. 4J). This indicates that half of 
the bone lining cells actively deposit mineral and that activation 
interrupts the mineral deposition process. Nearly all multinucleated 
osteoclasts expressed TRAP. The number of TRAP+ osteoclasts on 
DBP increased threefold when the osteoclasts were cocultured with 
osteoblasts, whereas TRAP+ osteoclast numbers on TCP were not 
affected by coculture with osteoblasts (Fig. 4K). This result, along 
with the increased motility of osteoclasts on DBP (Fig. 4F), indicates 
that DBP effectively facilitates cross-talk between osteoblasts and 
osteoclasts. These results suggest that DBP faithfully reproduces the 
bone remodeling cycle and provides a quantitative analytical platform 
to probe the multicellular processes of trabecular bone remodeling.
DBP-based trabecular bone organoid model recapitulates  
localized bone remodeling in trabecular bone cavities
In healthy trabecular bone, remodeling activity is confined to local 
spots surrounded by resting surfaces. The active and resting surfaces 
maintain different profiles of stimulatory and suppressive secretions, 
which results in a unique spatiotemporal pattern of regulatory mol-
ecules (3). Unbalanced remodeling with excessive bone resorption 
decreases bone thickness and increases cavity diameter (Fig. 5A). 
We hypothesized that localized bone remodeling is maintained by 
integrated metabolic and morphological regulation. To test this 
hypothesis, we simulated coexisting active and resting bone surfaces 
by culturing DBP disks with resting-state bone lining cells with DBP 
inserts with active osteoblasts. We created DBP inserts by fastening 
100-m-thick circles of DBP between two concentric O-rings. We 
built ring-shaped spacers to separate the resting-state and active-state 
surfaces to simulate the space in trabecular bone cavities (Fig. 5B). 
We used 6-, 10-, and 14-mm-diameter inserts to represent different- 
sized areas of active bone surface, and we used 0.5-, 1.5-, and 4.5-mm 
spacers to simulate different-sized trabecular bone spaces. We added 
BMMs to the space between the DBP disk and the DBP insert. The 
BMMs undergo osteoclastogenesis in response to spatiotemporal 
gradients of regulatory molecules. The ability to systematically 
manipulate the relative area of active to resting surfaces and the dis-
tance between them allowed investigation of the role of spatiotem-
poral profiles of regulatory molecules in localized bone remodeling. 
We named this setup the trabecular bone organoid model (Fig. 5C).
We began our study by examining the secretion profiles of the 
DBP inserts. Osteoblasts cultured on various-sized DBP inserts for 
1 week acquired the bone lining cell phenotype, with low RANKL 
and high OPG secretion (Fig. 5Di). We then stimulated the cells with 
VD3 and PGE2 (two times, 3 days apart, to ensure that all cells were 
activated) and observed that RANKL secretion increased in proportion 
to the size of the insert and OPG secretion decreased the same amount 
regardless of insert size (Fig. 5Dii). Next, we assembled the trabecular 
bone organoid model by placing a 16-mm DBP disk with bone lining 
cells in the well of a 24-well plate, adding 1 × 106 BMMs, and placing 
the stimulated DBP insert in the well over a spacer. We replaced the 
activated DBP insert after 3 days to maintain the level of stimulatory 
molecule secretion and terminated the coculture by 6 days (Fig. 5E).
We applied this trabecular bone organoid model to study the 
effect of spatiotemporal profiles of stimulatory and suppressive mol-
ecules on the activation of bone lining cells and the differentiation 
of BMMs into osteoclasts under two distinct scenarios. First, we ex-
amined the effect of activated surface area by testing three sizes of 
DBP inserts with one spacer height (0.5 mm). At the end of 6 days 
of coculture, we quantified the activation of lining cells by measur-
ing the ALP+ osteoblast area and quantified the differentiation of 
osteoclasts by counting the number of TRAP+ multinucleated cells. 
The results showed a stepwise increase in osteoclast number with 
increasing DBP insert size. ALP production of bone lining cells was 
significantly lower with the 14-mm insert than it was with the 10-mm 
insert (Fig. 5F). We then examined the impact of the gap (spacer) 
dimension by testing three spacer heights with one DBP insert size 
(14-mm diameter). After 6 days of coculture, we observed a stepwise 
decrease in osteoclast number with increasing spacer height. There 
was no significant difference in the ALP+ osteoblast area (Fig. 5G). 
These results indicate that BMMs and bone lining cells are both 
responsive to the extent and gradient of stimulative molecules, but 
differentiation of BMMs into osteoclasts occurs in a more localized 
pattern than activation of bone lining cells does.
Quantitative spatial mapping of cellular activities 
in the trabecular bone organoid model shows effect 
of spatiotemporal profiles of regulatory molecules on bone 
remodeling activity
We developed an algorithm for multiplex quantitative mapping of 
cellular bone remodeling activities to elucidate the effects of spatio-
temporal profiles of regulatory molecules on BMMs and bone lin-
ing cells. First, we conducted full surface scans of a DBP disk with 
four fluorescent channels: GFP, to distinguish cells from DBP; 
4′,6-diamidino-2-phenylindole (DAPI), to determine the number 
of nuclei in each cell; TRAP, to monitor osteoclast emergence; and 
ALP, to measure osteoblast activation (Fig. 6A and fig. S8). We 
averaged three independent results and generated spatial heatmaps 
of osteoblast and osteoclast activities relative to unstimulated con-
trols (Fig. 6B). For statistical comparison, we discretized the surface 
of the DBP disk into seven concentric zones with 1-mm-radius 
increments and plotted average fold changes of osteoclast and 
osteoblast activities within each zone. We drew a trend line and 
determined the slope and regression that describes the functional 
connection between spatiotemporal gradients of stimulatory mole-
cules and local bone remodeling activity. There was no significant 
difference in spatial distribution of fluorescent markers in the un-
stimulated controls (Fig. 6C).
We repeated multiplex quantitative imaging analysis for trabec-
ular bone organoid models with three insert sizes and three spacer 
heights. We placed 6-, 10-, or 14-mm-diameter activated DBP in-
serts above DBP disks with bone lining cells, separated by a 0.5-mm-
high spacer, in the well of a 24-well plate (Fig. 6D, i to iii). In wells 
with 6-mm inserts, the overall number of osteoclasts was no different 
from that of the unstimulated control, but spatial analysis revealed 
that the average fold change of osteoclasts in zones 1 and 2 was 
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10- and 14-mm DBP inserts revealed a stepwise increase in osteo-
clast number from the edge to the center of the DBP disk. Linear 
analysis of the correlation between osteoclastogenesis and distance 
from the center of the DBP disk showed that the slope values in-
creased with insert diameter. The average regression value was 0.66 
across all insert sizes. Next, we analyzed ALP expression change in 
the osteoblasts on the DBP disk. In wells with 6- and 10-mm DBP 
inserts, the overall percentage of ALP+ osteoblasts was not signifi-
cantly different from that of the unstimulated control; however, spa-
tial analysis revealed a 20% decrease in ALP+ osteoblasts in zones 1 
and 2 in wells with a 6-mm DBP insert and a 17% decrease in ALP+ 
osteoblasts in zones 1 through 3 of wells with a 10-mm DBP insert. 
The slope value decreased as DBP insert diameter increased from 
6 to 14 mm, and the average regression was 0.78. These results capture 
the effect of the size and distance of activated surfaces on localized 
activation of BMMs and bone lining cells.
We repeated the experiment with the 14-mm-diameter insert 
and three spacer heights: 0.5, 1.5, and 4.5 mm (Fig. 6D, iii to v). 
When the gap size increased, overall osteoclast differentiation de-
creased and localization to the central regions weakened. Slope 
values for osteoclast differentiation decreased as gap size increased. 
Regression analysis produced a value of 0.47 for the largest gap size, 
which indicates reduced impact of the activated surface on BMMs. 
When the gap size increased from 0.5 to 4.5 mm, the ALP expres-
sion slope values approached zero, which indicates poor correlation 
to a localized phenomenon. However, average ALP+ area did in-
crease with increasing spacer height. These results indicate that 
localized activation of bone lining cells is sensitive to concentration 
of stimulative molecules but less dependent on distance of activated 
surfaces than differentiation of BMMs is. Osteoclastogenesis was 
affected by both active area and distance but had a stronger correla-
tion with active area.
Fig. 5. The trabecular bone organoid model recapitulates coexisting active and resting bone surfaces. (A) Excessive bone remodeling results bone loss and changes 
in the trabecular bone morphology, which could compromise anatomical regulation of localized bone remodeling. (B) (i) DBP inserts were prepared by securing 100-m-thick 
DBP between two acrylic O-rings. (ii) DBP inserts were suspended above DBP disks with ring-shaped spacers. OBs cultured on a DBP insert. (C) The trabecular bone organoid 
model consists of a DBP insert that has been activated by VD3 and PGE2 suspended over a DBP disk containing bone lining cells. This juxtaposition of active and resting 
surfaces with a shared microenvironment simulates in vivo–relevant gradients of stimulatory and suppressive molecules. (D) (i) OBs cultured on DBP inserts acquired the 
bone lining cell secretory profile. (ii) VD3 and PGE2 stimulation increased RANKL secretion in proportion to surface area of insert (n = 5). (E) Experimental design. (F and 
G) DBP with bone lining cells was cocultured with BMMs and (F) three insert sizes or (G) three spacer heights. After 6 days of coculture, TRAP+ multinucleated OCs and 
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Functional coupling of osteoblasts and osteoclasts can occur by 
means of direct contact and by paracrine signaling (33). Therefore, 
we examined whether localized bone remodeling activity is affected 
by direct contact between osteoblasts and osteoclasts. The central 
zone of the DBP disk accommodates higher numbers of osteoblasts 
and osteoclasts than the peripheral zones. To distinguish between 
the effect of stimulatory molecules and the effect of physical contact 
between osteoclasts and osteoblasts, we repeated the experiment with 
6-mm DBP inserts. We measured the reduction of ALP in individual 
osteoblasts that were not in contact with osteoclasts in zone 1, which 
was exposed to high levels of stimulatory molecules, and in zone 6, 
which was exposed to low levels of stimulatory molecules (Fig. 6E 
and fig. S9). In zone 6, 55% of osteoblasts that were not in contact 
with osteoclasts were expressing ALP, whereas in zone 1, 22% of 
osteoblasts that did not have contact with osteoclasts were express-
ing ALP. This indicates that localized paracrine signaling activated 
bone lining cells. In both zones, osteoblasts that were in contact with 
osteoclasts were half as likely to express ALP as osteoblasts that were 
not in contact with osteoclasts. This indicates that osteoclasts acti-
vate bone lining cells via direct contact. These results suggest that 
there is a synergetic effect between localized stimulative paracrine 
signaling and osteoblast-osteoclast contact in the regulation of bone 
remodeling (Fig. 6F). Collectively, studies with the trabecular bone 
organoid model show the importance of spatiotemporal profiles of 
regulatory molecules and direct contact between osteoblasts and 
osteoclasts in regulating local trabecular bone remodeling.
DISCUSSION
To effectively reproduce the bone remodeling cycle, an in vitro bone 
tissue model should (i) be built from bone-relevant biomaterials 
that support intrinsic phenotypes and processes of osteoblasts and 
Fig. 6. Quantitative spatial mapping of OBs and OCs captures paracrine- and cellular contact–mediated regulation of bone remodeling. (A) DBP disks in a well 
plate were scanned with fluorescent channels for TRAP, ALP, GFP, and DAPI. The resulting 218 multiplex images were stitched together to represent the entire surface of 
the DBP disk. (B) Illustration of quantitative spatial imaging analysis for creating heatmaps of counts of TRAP+ and multinucleated (>3) OCs (top) and areas of ALP+ and 
GFP+ OBs (bottom). (C) (i) The DBP surface was discretized into seven concentric zones. (ii) Plot of activity levels for each region in control. (D) Representative heatmaps 
of ALP+ OB activity and regional OB and OC activities with linear analysis to correlate localized bone remodeling cellular activity and paracrine signaling from coculture 
experiments (n = 3 to 5). (E) Representative images of TRAP and ALP in central zone 1 and peripheral zone 6. (F) (i) Representative multiplex images showing delineation 
of OCs and OBs. (ii) Quantitative comparison of ALP+ OBs that are and are not in direct contact with OCs (n = 30). (G) Proposed mechanism of localized trabecular bone 
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osteoclasts, (ii) include bone lining cells to simulate activation and 
termination of bone remodeling, and (iii) coculture osteogenic and 
hematopoietic cells to reproduce their functional interactions in the 
regulation of bone metabolism. With this in mind, we developed a 
tissue-engineered trabecular bone organoid model to investigate 
spatiotemporal aspects of molecular and cellular regulation of 
bone remodeling.
The trabecular bone organoid model is based on DBP, a bone- 
derived biomaterial that supports intrinsic phenotypes and pro-
cesses of osteoblasts and osteoclasts—cells that exclusively reside 
and function on the bone surface. DBP serves as a functional tem-
plate on which osteoblasts rapidly deposit structural minerals, guided 
by the lamellar structure of the dense collagen, and resultantly form 
osteoid bone having a depth similar to that seen in vivo (34). DBP’s 
semitransparency makes it possible to monitor ongoing cellular pro-
cesses with fluorescent microscopy, and it is thin but durable enough 
to be handled easily. The consistent thickness and diameter of DBP 
support reproducible functional assays including osteoclast mineral 
resorption, bone surface healing, and osteoblast metabolic switch-
ing assays. DBP can be produced in large quantities—more than 
5000 from one bovine femur—for high-throughput and high-content 
experiments. The model’s modular design allows it to be integrated 
with other models to represent additional tissue complexity. For 
example, the space between two DBPs could be filled with marrow- 
mimicking viscous gels (35, 36), porous scaffolds (37, 38), or micro-
fluidic chips (39, 40).
Bone lining cells cover most of the trabecular bone surface and 
likely play a significant role in biochemical regulation (27), but they 
are difficult to study because we do not currently have definitive 
surface markers to distinguish bone lining cells from osteoblasts. 
DBP addresses this limitation by facilitating functional investigation 
of the bone lining cell phenotype. Our experiments captured pheno-
typic distinctions between bone lining cells and osteoblasts on TCP 
and DBP including morphology, migration, proliferation, and secre-
tion (fig. S10). Osteoblasts on DBP rapidly take on the bone lining 
cell phenotype, confirmed by the appearance of organized cellular 
morphology with gap junction communication, lower migration and 
proliferation, higher OPG secretion, and lower RANKL secretion 
than osteoblasts on TCP. The bone lining cells on DBP demonstrated 
the ability to regain osteoblast activity when they were replated on 
TCP in the phenotypic switching assay, physically disrupted in the 
bone surface healing assay, or chemically stimulated with VD3 and 
PGE2. These results are consistent with recent in vivo findings that 
bone lining cells are a major source of osteoblasts (29). Under chem-
ical stimulation, the bone lining cells switched from a suppressive 
secretory profile (high OPG and low RANKL) to a stimulatory 
secretory profile (low OPG and high RANKL). This suggests that 
bone lining cells use paracrine signaling to actively regulate the ex-
tent and duration of localized bone remodeling. To the best of our 
knowledge, this is the first demonstration of a bone remodeling cycle 
that includes the controlled and reversible activation of bone lining 
cells under physiologically relevant chemical stimulation. This makes 
it possible to study the initiation and termination of bone remodel-
ing, which is difficult to do with existing models.
We simulated the coexistence of active and resting bone tissue 
surfaces by placing DBP disks with bone lining cells and BMMs in 
multiwell plates with DBP inserts containing stimulated osteoblasts. 
This setup enabled us to integrate osteogenic and hematopoietic cells 
in the context of trabecular bone cavities. The combination of resting 
and active DBP surfaces created defined spatiotemporal profiles of 
regulatory molecules, and BMMs introduced into the gap responded 
to the regionally concentrated paracrine signaling. The effect of the 
gap size between the DBP disk and the insert was weak, possibly 
because the selected gap dimensions were too large to capture the 
gradient effect (13). The area of the activated DBP insert correlated 
positively with differentiation of BMMs into osteoclasts and activa-
tion of bone lining cells. Multiplex quantitative spatial analysis cap-
tured differences between BMMs and bone lining cells in the spatial 
pattern of response to paracrine molecules. These differences could 
be due to differences in cellular organization between osteogenic 
and hematopoietic cells (41). Osteogenic cells develop multicellular 
organization and gap junction communication and thus respond to 
stimuli as a collective group (28). This collective response could 
attenuate their responsiveness to the gradient of stimulant signals 
and result in weak responsiveness. On the other hand, hematopoietic 
cells reside and function individually in the bone marrow (41), which 
could cause them to be more sensitive to gradients of stimulative 
molecules and have a stronger spatial pattern of responsiveness. 
Our results suggest that trabecular bone thickness and the number 
of osteogenic cells and their connectivity may be critical to keep bone 
remodeling localized. Quantitative image analysis elucidated the 
functional coupling between osteoblasts and osteoclasts. Coculture 
with osteoblasts increased differentiation and migration of osteo-
clasts. ALP expression in osteoblasts appeared to decrease as a result 
of direct contact with osteoclasts. Interactions between osteoblasts 
and osteoclasts have been viewed as individual cellular interactions 
(42), but our results suggest that individual hematopoietic cells interact 
with groups of osteogenic cells. Along with metabolic and anatomical 
considerations, this may be another intrinsic regulatory mechanism 
that confines localized bone remodeling activity (Fig. 6G).
The trabecular bone organoid model has a number of limitations. 
(i) Like all in vitro models, the media composition in the trabecular 
bone organoid model has higher concentrations of growth factors 
and stimulants than that seen in the body. (ii) Although the model 
induces relevant osteogenic cell types and demonstrates functional 
bone remodeling activities, the quantities and maturation stages of 
cells may not reflect actual physiology. (iii) The model does not in-
clude osteocytes, which comprise more than 95% of bone cells (43). 
Emerging evidence indicates that osteocytes actively regulate bone 
surface remodeling by secreting OPG, RANKL, and sclerostin (43–45). 
(iv) Mechanical aspects of trabecular bone regulation are absent. 
Trabecular bone is under constant mechanical stress and undergoes 
repeated microfractures, which play an important role in initiating 
localized bone remodeling (46). (v) The role of hematopoietic cells 
in regulating bone remodeling is not fully addressed. One study re-
ported that more than 40% of bone marrow OPG is derived from B 
cells (47). In addition, allogeneic hematopoietic stem cell transplanta-
tion often accelerates osteoporotic bone loss (48), which suggests that 
hematopoietic cells can trigger imbalance in the microenvironment 
of the trabecular bone. (vi) The model does not adequately account 
for the inflammatory response. Trabecular bone contains bone mar-
row stromal cells that secrete various immunomodulatory molecules 
(49), and their profile is an important determinant of bone metabolism. 
We expect that incorporating these aspects of bone and marrow tis-
sue complexity will allow the model to better capture the complex 
and dynamic biological processes of the bone-marrow interface.
In future work, the trabecular bone organoid model could be 
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mouse cells with human bones and cells. The humanized trabecular 
bone organoid model could improve the predictive power of pre-
clinical studies and shorten the screening period for osteoporosis 
drugs, which currently takes 6 to 14 weeks in preclinical animal 
studies and 12 to 24 months in clinical trials (50). The model could 
also help researchers determine drugs’ mechanism of action and could 
be used to study the role of bone metabolism in hematopoietic stem 
cell regulation and dormant disseminated tumor cell biology. Future 
studies could directly compare the biological relevance and signifi-
cance of the trabecular bone organoid model with existing biomaterial 
platforms for functional osteogenic cell assays such as bone slices 
and hydroxyapatite-coated plates. We envision that this in vitro tra-
becular bone organoid model will facilitate the study of numerous 
aspects of bone biology in health and disease.
MATERIALS AND METHODS
All chemicals and materials were purchased from Sigma-Aldrich or 
Thermo Fisher Scientific unless specified. All animal procedures 
were approved by the Institutional Animal Care and Use Committee 
of the University of Massachusetts Amherst. Experiments with and 
handling of mice were conducted in accordance with federal, state, 
and local guidelines.
Preparation of demineralized compact bovine bone blocks
Bovine femurs were obtained from a local slaughterhouse and cut 
into chunks. Bone marrow was removed by centrifugation, and 
muscle tissues were removed with a scalpel. The chunks were then 
cut into smaller pieces and treated with a 1:1 chloroform-methanol 
solution to dissolve residual lipids and cell debris. The cleaned bone 
pieces were submerged in 400 ml of 1.2 N hydrochloric acid (HCl) 
solution to remove minerals from the bone matrix. Under atmo-
spheric pressure, the demineralization process of bovine compact 
bone (~1-cm thick) took more than 3 months with multiple rounds 
of HCl solution changes. To accelerate demineralization, we manu-
factured a programmable cyclic pressure chamber that consisted of 
an air-tight stainless-steel chamber (1 liter) and a solenoid valve 
programmed for various on/off intervals by an Arduino controller. 
Two to three cleaned bone pieces were submerged in HCl solution 
(200 ml) in a glass beaker that was then placed in the pressure chamber. 
The chamber was pressurized (≤4 bar) with in-house compressed 
air, which was then released after a programmed delay. After a first 
round of 24 hours of on/off pressure cycle operation, the demineral-
ized outer layer of bone and a periosteal fibrous film were removed 
with a razor blade to ensure full exposure of the bone matrix. In-
complete removal of a periosteal fibrous film causes inefficient and 
inconsistent demineralization. A second round of cyclic hydrostatic 
pressure was applied for 48 hours, the HCl solution was replaced, 
and the bone pieces were treated with another 48 hours of cyclic 
hydrostatic pressure. Last, the demineralized bone pieces were 
stabilized in deionized (DI) water overnight. To determine the depth 
of demineralization, the processed bone pieces were soaked in 
rhodamine dye solution for 10 min and then cut into two pieces. 
The cross-sectional images were analyzed with ImageJ to determine 
the depth of dye penetration. Optimal pressure and on/off cycles 
were determined by orthogonally changing the pressure (1, 2, 3, and 
4 bar) and on/off interval (10 s and 1, 5, and 10 min). The established 
protocol of 4 bar and 10-s on/off interval demineralized 1-cm thickness 
of compact bone piece within 1 week.
Radiographic imaging of demineralized bone blocks
Complete removal of mineral after the demineralization process was 
confirmed by radiographic imaging (Faxitron MX-20 X-ray cabinet) 
at 1 mA, 34 KV. Brightness of radiographs was quantitatively mea-
sured by ImageJ.
Preparation of DBP
Demineralized bone pieces were embedded in optimal cutting 
temperature medium, frozen at −20°C, and sliced into thin sections 
with a cryostat (CryoStar NX70). Thickness of slices was adjustable 
within the range of 10 to 150 m; the 20-m thickness was used in 
this study. The sectioned demineralized bone matrix was soaked in 
8% sodium dodecyl sulfate solution overnight to remove remain-
ing cell debris. Decellularization was confirmed by significantly re-
duced nuclear DAPI staining. Decellularized bone slices were then 
washed with DI water three times and stored in 70% ethanol at 
4°C. At this stage, the biomaterial is referred to as DBP. More than 
5000 quality DBPs were produced from one bovine femur. DBPs 
were cut with biopsy punches into circular shapes to be placed in 
multiwell plates; 6-, 10-, 14-, and 16-mm-diameter DBPs were 
prepared for 96-, 48-, 24-, and 12-well plates, respectively. Before 
use, DBPs were sterilized with 70% ethanol for 15 min and then 




Different thicknesses of DBP (20, 50, and 100 m) were cut into 
dog-bone shapes and gripped in a mechanical testing machine 
(ElectroForce 5500, TA Instruments). The DBP was stretched at a 
rate of 0.4 mm/s at room temperature, while applied tensile force 
and displacement of grips were continuously measured with XEI 
software (TA Instruments) until failure. A stress-strain curve was 
plotted in Excel from which Young’s moduli were determined.
Optical transparency
To quantify absorbance, a circular hole (20-mm diameter) was made 
at the center of the plastic bottom of a six-well plate with a laser 
cutting machine (Epilog Laser). DBPs of various thicknesses (20, 50, 
and 100 m) were placed over the hole, and a cover-glass slide was 
used as a control. The absorbance of DBPs and the glass slide was 
measured at a wavelength of 600 nm by a microplate reader (Synergy 2, 
BioTek). Relative optical transparency was determined by setting the 
cover-glass slide absorbance as 100%.
Surface morphology
Surface morphology of DBPs was observed optically under a tis-
sue culture microscope. DBPs were dried and coated with gold 
by a sputter coating machine (CR108, Cressington) and imaged 
with SEM (FEI Magellan) for detailed characterization of surface 
morphology.
Biochemical intactness of collagen fibers
CHP conjugated with fluorescein isothiocyanate was provided by 
M. Yu (University of Utah). For a positive control, damaged colla-
gen matrix was prepared by submerging DBP in an 80°C water bath. 
Before use, a CHP stock solution was incubated in the water bath at 
80°C for 5 min to dissociate coiled trimeric strands into monomeric 
strands. The heated solution was cooled on ice for 30 s. Intact and 
damaged DBPs were incubated overnight in 10 m of CHP solution 
at 4°C. The CHP bound on damaged collagen fibers was imaged 
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Retrieval and expansion of murine osteogenic cells
DsRed mice were obtained from B. Osborne (UMass Amherst), and 
GFP mice were obtained from The Jackson Laboratory (003291). 
Mice aged 6 to 12 weeks were used for the study. Femurs and tibias 
were harvested intact, and the surrounding connective tissues were 
removed. After the epiphyses were removed, the open-ended long 
bones were placed in 0.5-ml microcentrifuge tubes with holes punched 
in the bottom with a 26-gauge needle, and those tubes were inserted 
in 1.5-ml microcentrifuge tubes with the cap closed. During centrif-
ugation at 10,000g for 30 s, the entire bone marrow was released 
into the 1.5-ml tubes. The marrow-emptied long bones were gently 
cut into 1- to 2-mm lengths with a scalpel. These bone chips were 
placed in a T25 flask with 3 ml of digesting medium composed of 
-minimum essential medium (-MEM), 1% penicillin-streptomycin 
(PS), and 800 U of collagenase. After 1 hour of incubation at 37°C, 
the digesting medium was replaced with expansion medium com-
posed of -MEM supplemented with 1% PS and 10% fetal bovine 
serum (FBS). Osteogenic cells migrated out from bone chips and 
proliferated on TCP. Once 80% confluency was achieved, the cells 
were detached with 1% trypsin/EDTA and subcultured in T175 flasks 
for further expansion. Cells were cultured at 37°C in a humidified 
atmosphere containing 5% CO2. Cells used for experiments were 
subcultured less than five times.
Osteoblast differentiation
Expanded osteogenic cells were cultured in osteoblast differentiation 
medium composed of -MEM supplemented with 1% PS, 10% FBS, 
10 mM -glycerophosphate, and 200 M l-ascorbic acid.
Osteoblast functional assays
Osteogenic cell morphology and alignment
The osteoblasts were cultured for 1 week in osteogenic differentia-
tion medium and fixed with 4% paraformaldehyde. Cytoskeletal actin 
filaments and nuclei were stained with phalloidin conjugated with 
Alexa Fluor 488 and DAPI, respectively. Confocal microscopy 
(Zeiss Cell Observer SD) was used for imaging. Cell alignment an-
gles were measured with the angle tool function of ImageJ. Cell 
alignment angles on TCP and DBP were measured with respect to the 
horizontal line and the average of collagen alignment of DBP, re-
spectively. The 0° angle was set on the basis of collagen alignment 
angle of DBP. A total of 100 measurements from 10 different sam-
ples were used to generate a circular diagram that was produced in 
MATLAB.
Osteogenic migration under long-term fluorescent  
time-lapse imaging
Endogenous GFP and DsRed fluorescence of osteogenic cells was 
detected with an inverted fluorescent microscope with a 10× objective 
lens (LumaScope 720, Etaluma) that operates inside of a CO2 incu-
bator. Quantitative cell migration analysis was conducted by process-
ing obtained images using TrackMate in ImageJ. Time-lapse movies 
were prepared with ImageJ.
Collagen deposition and alignment
A resonant scanning multiphoton microscope (Nikon A1MP) was 
used to image collagen fibers deposited by osteoblasts via second 
harmonic generation with a 25× objective lens. Collagen fibers were 
excited at 810 nm. Alignment angles of individual collagen fibers 
were measured with the angle tool function of ImageJ. Collagen 
alignment angle on TCP and DBP was measured with respect to the 
horizontal line on TCP and the average of collagen alignment on 
DBP. A total of 100 measurements from 10 different samples were 
used to generate a circular diagram.
Mineral deposition
Mature osteoblasts were cultured on TCP and DBP for up to 3 weeks 
with osteogenic differentiation medium. At the end of the experi-
ment, cells were fixed with 4% formaldehyde for 5 min, washed 
three times with DI water, and stained.
Alizarin red mineral staining. Fixed samples were stained with 
alizarin red (American MasterTech) for 30 min and washed with DI 
water until the washing solution appeared clear. Mineral stained with 
alizarin red was imaged with an optical microscope (EVOS) with a 
10× objective lens. Deposited mineral was quantified by solubilizing 
alizarin red in 10% acetic acid for 1 hour and measuring the absorb-
ance of the solution at 405 nm with a microplate reader (BioTek).
Fluorochrome calcein mineral staining. Because calcein emits green 
fluorescence, osteogenic cells were derived from DsRed mice. Fixed 
samples were stained with 50 M calcein solution. The fluorescence 
of calcein and DsRed osteogenic cells was imaged under confocal 
microscopy with 10× and 20× objective lenses.
Chemical remineralization of DBP in SBF. To prepare 1 liter of 
10× SBF solution, 58.43 g (1 M) of NaCl, 0.373 g (5 mM) of KCl, 
3.675 g (25 mM) of CaCl2·2H2O, and 1.016 g (5 mM) of MgCl2·6H2O 
were dissolved in 600 ml of DI water (solution 1). In a separate glass 
beaker, 0.42 g (10 mM) of Na2HPO4 was dissolved in 30 ml of DI 
water (solution 2). Solution 2 and HCl were added to solution 1 
dropwise to maintain pH below 4 to avoid calcium precipitation. DI 
water was also added to bring the final volume up to 1 liter while 
maintaining a pH of 4. For calcium precipitation, a small amount of 
NaHCO3 was added in the 10× SBF solution to increase pH. For 
remineralization, DBP was submerged in the 10× SBF solution im-
mediately after adding NaHCO3 and incubated at 37°C for 5 hours.
Surface characterization
Imaging surface morphology. SEM was used to obtain high-resolution 
surface morphology of DBP, osteogenic cells, and deposited minerals. 
Osteogenic cells were fixed with 2.5% glutaraldehyde and rinsed with 
DI water. The fixed cells were dehydrated in sequential graded ethanol 
solution (50, 70, 80, 90, 95, and 100%) for 10 min each. The cells 
were dried at room temperature with hexamethyldisilazane. Before 
imaging, samples were coated with gold with a sputter coating machine.
Measuring surface roughness. Remineralized DBPs were heated 
at 500°C for 5 hours to thermally decompose the organic components. 
The remaining mineral layers were analyzed by an optical profiler 
(Nexview, Zygo) that visualized 3D surface morphology and quanti-
tatively presented surface roughness.
Characterization of bone lining cells
DBP was seeded with 1 × 106 osteoblasts/mm2. After 1 week of cul-
ture with differentiation medium, osteoblasts fully covered the sur-
face and exhibited the bone lining cell phenotype as characterized 
by the following methods.
Immunofluorescent staining of Ki67
Osteoblasts were fixed with 4% paraformaldehyde for 5 min at room 
temperature and washed three times with PBS. The fixed cells were 
incubated in PBS containing 0.1% Triton X-100 for 10 min and 
washed three times with PBS. For blocking, the cells were incubated 
with 10% goat serum and 1% bovine serum albumin (BSA) in PBS 
for 2 hours at room temperature. A primary rabbit anti-mouse Ki67 
antibody (1:200 dilution in the blocking solution) was applied to the 
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a secondary goat anti-rabbit antibody conjugated with Alexa Fluor 
647 (1:200 dilution in the blocking solution) was applied and incu-
bated for 1 hour at room temperature. After three washes with PBS, 
a DAPI solution (100 l of 10 ng/l) was added before imaging. 
Images were obtained with fluorescence and confocal microscopy.
Bone surface healing assay
The cell surface was scraped with a sterilized acrylic rod (0.5-mm 
diameter). Time-lapse fluorescent imaging of the scratched area was 
conducted for 72 hours at 30-min intervals (LumaScope 720) in a 
CO2 incubator. Recovery of the scratched area by awakened bone 
lining cells was quantified with ImageJ. Transiently increased osteo-
genic cell migration rates were measured with TrackMate in ImageJ.
Osteoblast phenotypic switching assay
Osteoblasts cultured on DBP with differentiation medium acquired 
a bone lining cell phenotype and reached full confluence after 2 weeks. 
The DBP with confluent bone lining cells was transferred to a T25 
flask, and 3 ml of -MEM with 800 U of collagenase II was added. 
After 1 hour of incubation at 37°C, the degraded DBP left behind 
mineralized fragments. The collagenase solution was carefully re-
moved, and 5 ml of expansion medium was added. Osteogenic cells 
migrated out of the mineralized parts and culture-expanded on TCP. 
Expanded osteoblasts on TCP were detached with trypsin and EDTA 
and reintroduced on DBP to reinduce the bone lining cell phenotype, 
which is considered one cycle of this osteoblast phenotypic switching 
assay. In each cycle, the time to reach 80% confluency on TCP and the 
amount of mineral deposited in the 2-week culture on DBP were deter-
mined. We repeated three cycles of this phenotypic switching assay.
Characterization of gap junction communication among 
osteogenic cells on DBP
Immunofluorescent staining of connexin 43
Osteoblasts on DBP were fixed with 4% paraformaldehyde for 5 min 
at room temperature. The cells were then washed three times with 
PBS. Washed cells were incubated for 10 min with PBS containing 
0.1% Triton X-100 and then washed three times with PBS. For the 
blocking step, the cells were incubated with 10% goat serum and 1% 
BSA in PBS for 2 hours at room temperature. Primary and secondary 
antibodies were diluted 1:50 and 1:200 in blocking solution, respec-
tively. The cells were incubated overnight with rabbit anti-mouse 
connexin 43 antibody at 4°C. After washing three times with PBS, 
goat anti-rabbit antibodies with Alexa Fluor 647 were added to sam-
ples and incubated for 1 hour at room temperature. After washing 
with PBS three times, phalloidin conjugated with Alexa Fluor 488 
and DAPI (100 l of 10 ng/l) was added. Fluorescence imaging was 
conducted with a confocal microscope.
Time-lapse fluorescence imaging of Ca2+ influx
For gap junction–mediated Ca2+ imaging, osteoblasts on DBP were 
incubated in calcium-free PBS for 5 hours and then loaded with 5 M 
Fluo-4 AM in calcium-free PBS. After 1-hour incubation, the osteo-
blasts were washed with calcium-free PBS three times. Time-lapse 
fluorescent imaging of Ca2+ influx under potassium stimulation was 
performed with a confocal microscope with a 20× objective lens at 
0.5 s per frame for 5 min (Cell Observer SD). The average pixel inten-
sity of fluorescence in each individual cell was quantified with ImageJ.
Isolation of murine BMMs
Femoral and tibial bones were harvested, and the bone marrow was 
isolated as mentioned above. On average, more than 2 × 107 bone 
marrow cells were harvested from each mouse. Isolated whole bone 
marrow cells were plated on TCP with expansion medium supple-
mented with macrophage colony-stimulating factor (M-CSF; 20 ng/ml). 
After 3 days of culture, floating BMMs were separated from adherent 
stromal cells for osteoclast differentiation experiments.
Osteoclast differentiation
BMMs were seeded on TCP, remineralized decellularized DBP, and 
DBP with osteoblasts with osteoclast differentiation medium com-
posed of -MEM supplemented with 10% FBS, 1% PS, RANKL 
(40 ng/ml), and M-CSF (20 ng/ml). Osteoclast differentiation medium 
was replaced every 3 days.
Osteoclast characterization and functional assays
Osteoclast morphology and size
BMMs cultured in osteoclast differentiation medium were fixed with 
4% paraformaldehyde. Actin filaments and nuclei were stained with 
phalloidin conjugated with Alexa Fluor 488 and DAPI, respectively. 
Confocal microscopy (Cell Observer SD) was used to visualize 
osteoclast-specific actin-ring structure with a nucleus. The number 
of nuclei in a single osteoclast was counted manually in ImageJ, and 
cells with more than three nuclei were considered to be mature 
osteoclasts. The size of an osteoclast cell body was calculated from 
the average vertical and horizontal diameters.
Osteoclast migration under long-term fluorescent  
time-lapse imaging
Endogenous GFP or DsRed fluorescence of BMMs was detected with 
a 10× objective lens (LumaScope 720). The resulting images were 
analyzed with TrackMate in ImageJ to quantify cell migration, and 
time-lapse movies were prepared in ImageJ.
Osteoclast mineral resorption confirmed by SEM
Scanning electron microscopy (FEI Magellan 400) was used to confirm 
mineral resorption by osteoclasts. Osteoclasts emerged after 7 to 10 days 
of culture in osteoclast differentiation medium and were fixed with 
2.5% glutaraldehyde and rinsed with DI water. The cells were then 
dehydrated in ethanol and dried at room temperature with hexam-
ethyldisilazane. Before SEM imaging, samples were coated with gold.
Osteoblast and osteoclast coculture experiments
Osteogenic cells retrieved from GFP mice were cultured on DBP in 
a 48-well plate with osteoblast differentiation medium for 1 week to 
induce a mature bone lining cell phenotype. Then, 1 × 106 BMMs 
retrieved from DsRed mice were introduced into the wells in stim-
ulation medium composed of -MEM, 10% FBS, 1% PS, PGE2 
(1 M), and VD3 (10 nM).
Functional characterization of osteoblast and  
osteoclast coculture
Determining OPG and RANKL secretion by enzyme-linked 
immunosorbent assay
OPG and RANKL proteins produced by osteoblasts were measured 
in conditioned media with an enzyme-linked immunosorbent assay 
(ELISA) kit (R&D Systems). Media samples were taken over the cul-
ture period and diluted 1:5  in reagent diluent to bring OPG and 
RANKL concentrations within the detection range of the assay. The 
assay was performed according to the manufacturer’s instructions.
Time-lapse fluorescent imaging of the coculture and  
quantitative imaging analysis
GFP osteoblasts and DsRed-osteoclast precursor cells were cultured 









Park et al., Sci. Adv. 2021; 7 : eabd6495     20 January 2021
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
14 of 15
10× objective lens with a fluorescence microscope (LumaScope 720) 
operated in a CO2 incubator. Time-lapse movies were prepared 
in ImageJ.
TRAP activity
Cells were fixed in 4% formaldehyde and washed three times with 
DI water. Osteoclast differentiation was evaluated with a TRAP detec-
tion kit (387A, Sigma-Aldrich) according to the vendor’s protocol. 
Stained cells were observed with an optical microscope.
ALP activity
Cells were fixed with 4% paraformaldehyde for 5 min and then washed 
with DI water three times. ALP detection kits (86C, Sigma-Aldrich) 
were used to analyze the ALP activity of osteoblasts. The staining 
was performed according to the vendor’s protocol. Stained cells were 
observed with an optical microscope.
Preparation of DBP inserts
Inner and outer 0-rings were fabricated to interlock around DBP 
disks. The rings were designed in Adobe Illustrator and cut with a 
laser cutting machine from 1-mm-thick acrylic plates. The outer 
0-rings were slightly larger than the DBP circles and had four side-
bars to center the DBP insert in the well. The diameters of the inner 
O-rings were 6, 10, and 14 mm. Ring-shaped spacers were cut from 
acrylic plates with 0.5-, 1.5-, and 4.5-mm thicknesses. Fabricated 
O-ring inserts and spacers were sterilized with 70% ethanol before 
use in cell culture. Sterilized DBP rings were washed with PBS three 
times and placed in a 24-well plate before cell seeding.
Experimental setup for trabecular bone organoid model 
with a DBP insert
For the resting state, 1.5 × 105 osteoblasts were seeded on DBP 
(16-mm diameter) in a 24-well plate and cultured with differentia-
tion medium for more than 1 week. For the activated state, 1.5 × 105, 
7 × 104, and 2 × 104 osteoprogenitor cells were first seeded on 15-, 
12-, and 8-mm-diameter DBP circles, respectively. The osteoblast 
seeded DBPs were gripped by the two concentrically assembled 
O-rings and cultured more than 7 days with differentiation medium. 
Bone lining cells on DBP inserts were stimulated with VD3 and PGE2 
for two rounds of 3 days each. Next, 1 × 106 BMMs were added to 
each well. Stimulated DBP inserts were transferred to the 24-well 
plates with the osteoblasts facing the bottom of the plate. The dis-
tance between the resting and activated DBP surfaces was controlled 
with 0.5-, 1.5-, and 4.5-mm thick, ring-shaped spacers. During co-
culture, the activated DBP insert was replaced with a newly activated 
DBP insert every 3 days to maintain the profile of secretory molecules 
from activated osteoblasts. Multiplex immunofluorescent staining 
was performed after 6 days of coculture.
Multiplex immunofluorescent staining and imaging
Osteoblasts and BMMs retrieved from GFP mice were used to per-
form multiplex imaging. After osteoblasts and osteoclasts were co-
cultured in the trabecular bone organoid model, cells on DBPs in 
the 24-well plate bottom were fixed in 4% paraformaldehyde for 
5 min at room temperature and washed three times with PBS. The 
fixed cells were incubated for 10 min with PBS containing 0.1% Triton 
X-100 and washed with PBS three times. The samples were blocked 
with 10% donkey serum and 1% BSA in PBS for 2 hours at room 
temperature. Primary goat anti-mouse ALP and rabbit anti-mouse 
TRAP antibodies were diluted 1:200 in blocking solution and added 
on the samples. After overnight incubation at 4°C, the cells were 
washed three times with PBS. Secondary donkey anti-goat antibodies 
conjugated with Alexa Fluor 568 and donkey anti-rabbit secondary 
antibodies conjugated with Alexa Fluor 647 were diluted 1:200 in 
blocking solution and added to samples. After 1-hour incubation at 
room temperature, the cells were washed with PBS three times. Before 
imaging, DAPI solution was added (200 l of 10 ng/l). The entire 
surface of multiplex imaging samples was scanned with fluorescence 
and confocal microscopes with 10× objective lenses.
Quantitative image analysis algorithm of multiplex 
immunofluorescent images
TRAP+ multinucleated osteoclast number and ALP+ osteoblast areas 
on DBP placed in a 24-well plate were quantified from multiplex 
immunofluorescent images with CellProfiler. Automatic quantifi-
cation was validated by comparing the results against manually 
obtained data. For total analysis, osteoclast number and ALP+ osteo-
blast area were averaged from three independent experiments. Fold 
change of osteoclast number and percentage of ALP+ osteoblast area 
were calculated on the basis of the results from unstimulated control. 
For regional analysis, the bottom DBP was discretized into seven 
concentric regions in which TRAP+ osteoclast number and ALP+ 
osteoblast area were calculated. Fold change was determined by com-
paring the results of matching control experiment. For the character-
ization of ALP reduction of osteoblasts in contact with osteoclasts, 
TRAP+ osteoclasts were identified. Then, osteoblasts that were and 
were not in direct contact with osteoclasts were manually identified. 
Last, ALP expression area of the selected osteoblasts was quantified 
using ImageJ.
Statistics
All measurements were collected in at least triplicate and expressed 
as means ± SD. P values were calculated using the t test and one-way 
analysis of variance (ANOVA) with post hoc Bonferroni test in sta-
tistical package for the social sciences (SPSS, IBM). ANOVA was 
used to assess significance, with *P < 0.05 and **P < 0.01.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/7/4/eabd6495/DC1
View/request a protocol for this paper from Bio-protocol.
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